Julia Amann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Julia Amann has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Sara Rubinelli
Faculty of Health Sciences and Medicine, Universitat Luzern, Switzerland
8 shared publications - Maddalena Fiordelli
Institute of Public Health, Università della Svizzera italiana, Switzerland
7 shared publications - Mirjam Brach
Swiss Paraplegic Research, Nottwil, Switzerland
7 shared publications - Anke Scheel-Sailer
Centre for Rehabilitation and Sport Medicine, Inselspital, University Hospital of Bern, Bern, Switzerland
6 shared publications - Claudia Zanini
Swiss Paraplegic Research, Nottwil, Switzerland
5 shared publications Sara Rubinelli
Swiss Paraplegic Research, Nottwil, Switzerland
4 shared publications
Latest Publications
- Open Access
- 29 October 2025
- Published by Springer Nature in BMC Medical Ethics
- Vol. 26 (1) , 1-15
Operationalizing AI ethics in medicine—a co-creation workshop study
Background: A majority of AI ethics frameworks focus on high-level principles but lack actionable guidance. Effectively implementing AI in projects requires the operationalization of AI ethics, translating principles into requirements. This paper proposes a novel method for operationalizing AI ethics through co-creation workshops. Methods: The study adopted a qualitative, participatory research approach. Stakeholders from the VALIDATE project, a Horizon Europe action developing an AI-based clinical decision support system for stroke patient stratification, were divided into five diverse teams. The workshops aimed to: (i) determine the low-level ethical requirements stakeholders considered essential for the project, and (ii) identify requirements not included in the EU Trustworthy AI Guidelines. The methodology included storytelling, content analysis to identify ethical issues and dilemmas, eliciting quantifiable requirements using a standardized planning language (Planguage), and a procedural feedback process. Results: The workshops identified explainability, privacy, model robustness, model validity, epistemic authority, fairness, and transparency as key ethical issues. Participants drafted low-level requirements related to privacy , explainability , transparency , and validity . Six issues ( time sensitivity, validity, prevention of harm to patients, patient-inclusive care, quality of life, and lawsuit prevention) could not be mapped to the EU Guidelines. Participants did not draft requirements in relation to the latter issues. Challenges included the diverse interpretations of concepts, such as validity . Participants generally had favorable impressions of the workshops, although they found formulating requirements in Planguage format more challenging than storytelling and topic prioritization. Conclusions: The workshops elicited concrete, quantifiable, and actionable requirements, which were useful in developing a project-specific ethical framework. The proposed methodology is resource-efficient and requires fewer AI ethics experts than existing methods while remaining compatible with established guidelines. Procedural feedback results suggest that participants and facilitators would benefit from additional training in the use of Planguage. Potential challenges included the impact of power dynamics among participants on discussions, blind spots due to overlooked issues, and the absence of stroke patients among the participants.
- 29 October 2025
- Published by Springer Nature in BMC Medical Ethics
- Vol. 26 (1) , 1-15
Open AccessOperationalizing AI ethics in medicine—a co-creation workshop study
Background: A majority of AI ethics frameworks focus on high-level principles but lack actionable guidance. Effectively implementing AI in projects requires the operationalization of AI ethics, translating principles into requirements. This paper proposes a novel method for operationalizing AI ethics through co-creation workshops. Methods: The study adopted a qualitative, participatory research approach. Stakeholders from the VALIDATE project, a Horizon Europe action developing an AI-based clinical decision support system for stroke patient stratification, were divided into five diverse teams. The workshops aimed to: (i) determine the low-level ethical requirements stakeholders considered essential for the project, and (ii) identify requirements not included in the EU Trustworthy AI Guidelines. The methodology included storytelling, content analysis to identify ethical issues and dilemmas, eliciting quantifiable requirements using a standardized planning language (Planguage), and a procedural feedback process. Results: The workshops identified explainability, privacy, model robustness, model validity, epistemic authority, fairness, and transparency as key ethical issues. Participants drafted low-level requirements related to privacy , explainability , transparency , and validity . Six issues ( time sensitivity, validity, prevention of harm to patients, patient-inclusive care, quality of life, and lawsuit prevention) could not be mapped to the EU Guidelines. Participants did not draft requirements in relation to the latter issues. Challenges included the diverse interpretations of concepts, such as validity . Participants generally had favorable impressions of the workshops, although they found formulating requirements in Planguage format more challenging than storytelling and topic prioritization. Conclusions: The workshops elicited concrete, quantifiable, and actionable requirements, which were useful in developing a project-specific ethical framework. The proposed methodology is resource-efficient and requires fewer AI ethics experts than existing methods while remaining compatible with established guidelines. Procedural feedback results suggest that participants and facilitators would benefit from additional training in the use of Planguage. Potential challenges included the impact of power dynamics among participants on discussions, blind spots due to overlooked issues, and the absence of stroke patients among the participants.
- Open Access
- 31 January 2023
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 2 (1) , e0000189
Beyond high hopes: A scoping review of the 2019–2021 scientific discourse on machine learning in medical imaging
Machine learning has become a key driver of the digital health revolution. That comes with a fair share of high hopes and hype. We conducted a scoping review on machine learning in medical imaging, providing a comprehensive outlook of the field’s potential, limitations, and future directions. Most reported strengths and promises included: improved (a) analytic power, (b) efficiency (c) decision making, and (d) equity. Most reported challenges included: (a) structural barriers and imaging heterogeneity, (b) scarcity of well-annotated, representative and interconnected imaging datasets (c) validity and performance limitations, including bias and equity issues, and (d) the still missing clinical integration. The boundaries between strengths and challenges, with cross-cutting ethical and regulatory implications, remain blurred. The literature emphasizes explainability and trustworthiness, with a largely missing discussion about the specific technical and regulatory challenges surrounding these concepts. Future trends are expected to shift towards multi-source models, combining imaging with an array of other data, in a more open access, and explainable manner.
- 31 January 2023
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 2 (1) , e0000189
Open AccessBeyond high hopes: A scoping review of the 2019–2021 scientific discourse on machine learning in medical imaging
Machine learning has become a key driver of the digital health revolution. That comes with a fair share of high hopes and hype. We conducted a scoping review on machine learning in medical imaging, providing a comprehensive outlook of the field’s potential, limitations, and future directions. Most reported strengths and promises included: improved (a) analytic power, (b) efficiency (c) decision making, and (d) equity. Most reported challenges included: (a) structural barriers and imaging heterogeneity, (b) scarcity of well-annotated, representative and interconnected imaging datasets (c) validity and performance limitations, including bias and equity issues, and (d) the still missing clinical integration. The boundaries between strengths and challenges, with cross-cutting ethical and regulatory implications, remain blurred. The literature emphasizes explainability and trustworthiness, with a largely missing discussion about the specific technical and regulatory challenges surrounding these concepts. Future trends are expected to shift towards multi-source models, combining imaging with an array of other data, in a more open access, and explainable manner.
- Top Cited PapersOpen Access
- 11 January 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (1) , e0279088
Expectations and attitudes towards medical artificial intelligence: A qualitative study in the field of stroke
Introduction: Artificial intelligence (AI) has the potential to transform clinical decision-making as we know it. Powered by sophisticated machine learning algorithms, clinical decision support systems (CDSS) can generate unprecedented amounts of predictive information about individuals’ health. Yet, despite the potential of these systems to promote proactive decision-making and improve health outcomes, their utility and impact remain poorly understood due to their still rare application in clinical practice. Taking the example of AI-powered CDSS in stroke medicine as a case in point, this paper provides a nuanced account of stroke survivors’, family members’, and healthcare professionals’ expectations and attitudes towards medical AI.Methods: We followed a qualitative research design informed by the sociology of expectations, which recognizes the generative role of individuals’ expectations in shaping scientific and technological change. Semi-structured interviews were conducted with stroke survivors, family members, and healthcare professionals specialized in stroke based in Germany and Switzerland. Data was analyzed using a combination of inductive and deductive thematic analysis.Results: Based on the participants’ deliberations, we identified four presumed roles that medical AI could play in stroke medicine, including an administrative, assistive, advisory, and autonomous role AI. While most participants held positive attitudes towards medical AI and its potential to increase accuracy, speed, and efficiency in medical decision making, they also cautioned that it is not a stand-alone solution and may even lead to new problems. Participants particularly emphasized the importance of relational aspects and raised questions regarding the impact of AI on roles and responsibilities and patients’ rights to information and decision-making. These findings shed light on the potential impact of medical AI on professional identities, role perceptions, and the doctor-patient relationship.Conclusion: Our findings highlight the need for a more differentiated approach to identifying and tackling pertinent ethical and legal issues in the context of medical AI. We advocate for stakeholder and public involvement in the development of AI and AI governance to ensure that medical AI offers solutions to the most pressing challenges patients and clinicians face in clinical care.
- 11 January 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (1) , e0279088
Top Cited PapersOpen AccessExpectations and attitudes towards medical artificial intelligence: A qualitative study in the field of stroke
Introduction: Artificial intelligence (AI) has the potential to transform clinical decision-making as we know it. Powered by sophisticated machine learning algorithms, clinical decision support systems (CDSS) can generate unprecedented amounts of predictive information about individuals’ health. Yet, despite the potential of these systems to promote proactive decision-making and improve health outcomes, their utility and impact remain poorly understood due to their still rare application in clinical practice. Taking the example of AI-powered CDSS in stroke medicine as a case in point, this paper provides a nuanced account of stroke survivors’, family members’, and healthcare professionals’ expectations and attitudes towards medical AI.Methods: We followed a qualitative research design informed by the sociology of expectations, which recognizes the generative role of individuals’ expectations in shaping scientific and technological change. Semi-structured interviews were conducted with stroke survivors, family members, and healthcare professionals specialized in stroke based in Germany and Switzerland. Data was analyzed using a combination of inductive and deductive thematic analysis.Results: Based on the participants’ deliberations, we identified four presumed roles that medical AI could play in stroke medicine, including an administrative, assistive, advisory, and autonomous role AI. While most participants held positive attitudes towards medical AI and its potential to increase accuracy, speed, and efficiency in medical decision making, they also cautioned that it is not a stand-alone solution and may even lead to new problems. Participants particularly emphasized the importance of relational aspects and raised questions regarding the impact of AI on roles and responsibilities and patients’ rights to information and decision-making. These findings shed light on the potential impact of medical AI on professional identities, role perceptions, and the doctor-patient relationship.Conclusion: Our findings highlight the need for a more differentiated approach to identifying and tackling pertinent ethical and legal issues in the context of medical AI. We advocate for stakeholder and public involvement in the development of AI and AI governance to ensure that medical AI offers solutions to the most pressing challenges patients and clinicians face in clinical care.
- Open Access
- 29 July 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Technology and Society
- Vol. 3 (4) , 272-289
Assessing Trustworthy AI in Times of COVID-19: Deep Learning for Predicting a Multiregional Score Conveying the Degree of Lung Compromise in COVID-19 Patients
The paper’s main contributions are twofold: to demonstrate how to apply the general European Union’s High-Level Expert Group’s (EU HLEG) guidelines for trustworthy AI in practice for the domain of healthcare; and to investigate the research question of what does “trustworthy AI” mean at the time of the COVID-19 pandemic. To this end, we present the results of a post-hoc self-assessment to evaluate the trustworthiness of an AI system for predicting a multi-regional score conveying the degree of lung compromise in COVID-19 patients, developed and verified by an interdisciplinary team with members from academia, public hospitals, and industry in time of pandemic. The AI system aims to help radiologists to estimate and communicate the severity of damage in a patient’s lung from Chest X-rays. It has been experimentally deployed in the radiology department of the ASST Spedali Civili clinic in Brescia (Italy) since December 2020 during pandemic time. The methodology we have applied for our post-hoc assessment, called Z-Inspection, uses socio-technical scenarios to identify ethical, technical and domain-specific issues in the use of the AI system in the context of the pandemic.
- 29 July 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Technology and Society
- Vol. 3 (4) , 272-289
Open AccessAssessing Trustworthy AI in Times of COVID-19: Deep Learning for Predicting a Multiregional Score Conveying the Degree of Lung Compromise in COVID-19 Patients
The paper’s main contributions are twofold: to demonstrate how to apply the general European Union’s High-Level Expert Group’s (EU HLEG) guidelines for trustworthy AI in practice for the domain of healthcare; and to investigate the research question of what does “trustworthy AI” mean at the time of the COVID-19 pandemic. To this end, we present the results of a post-hoc self-assessment to evaluate the trustworthiness of an AI system for predicting a multi-regional score conveying the degree of lung compromise in COVID-19 patients, developed and verified by an interdisciplinary team with members from academia, public hospitals, and industry in time of pandemic. The AI system aims to help radiologists to estimate and communicate the severity of damage in a patient’s lung from Chest X-rays. It has been experimentally deployed in the radiology department of the ASST Spedali Civili clinic in Brescia (Italy) since December 2020 during pandemic time. The methodology we have applied for our post-hoc assessment, called Z-Inspection, uses socio-technical scenarios to identify ethical, technical and domain-specific issues in the use of the AI system in the context of the pandemic.
- Open Access
Digital twins and hybrid modelling for simulation of physiological variables and stroke risk
One of the more interesting ideas for achieving personalized, preventive, and participatory medicine is the concept of a digital twin. A digital twin is a personalized computer model of a patient. So far, digital twins have been constructed using either mechanistic models, which can simulate the trajectory of physiological and biochemical processes in a person, or using machine learning models, which for example can be used to estimate the risk of having a stroke given a cross-section profile at a given timepoint. These two modelling approaches have complementary strengths which can be combined into a hybrid model. However, even though hybrid modelling combining mechanistic modelling and machine learning have been proposed, there are few, if any, real examples of hybrid digital twins available. We now present such a hybrid model for the simulation of ischemic stroke. On the mechanistic side, we develop a new model for blood pressure and integrate this with an existing multi-level and multi-timescale model for the development of type 2 diabetes. This mechanistic model can simulate the evolution of known physiological risk factors (such as weight, diabetes development, and blood pressure) through time, under different intervention scenarios, involving a change in diet, exercise, and certain medications. These forecast trajectories of the physiological risk factors are then used by a machine learning model to calculate the 5-year risk of stroke, which thus also can be calculated for each timepoint in the simulated scenarios. We discuss and illustrate practical issues with clinical implementation, such as data gathering and harmonization. By improving patients’ understanding of their body and health, the digital twin can serve as a valuable tool for patient education and as a conversation aid during the clinical encounter. As such, it can facilitate shared decision-making, promote behavior change towards a healthy lifestyle, and improve adherence to prescribed medications.
Open AccessDigital twins and hybrid modelling for simulation of physiological variables and stroke risk
One of the more interesting ideas for achieving personalized, preventive, and participatory medicine is the concept of a digital twin. A digital twin is a personalized computer model of a patient. So far, digital twins have been constructed using either mechanistic models, which can simulate the trajectory of physiological and biochemical processes in a person, or using machine learning models, which for example can be used to estimate the risk of having a stroke given a cross-section profile at a given timepoint. These two modelling approaches have complementary strengths which can be combined into a hybrid model. However, even though hybrid modelling combining mechanistic modelling and machine learning have been proposed, there are few, if any, real examples of hybrid digital twins available. We now present such a hybrid model for the simulation of ischemic stroke. On the mechanistic side, we develop a new model for blood pressure and integrate this with an existing multi-level and multi-timescale model for the development of type 2 diabetes. This mechanistic model can simulate the evolution of known physiological risk factors (such as weight, diabetes development, and blood pressure) through time, under different intervention scenarios, involving a change in diet, exercise, and certain medications. These forecast trajectories of the physiological risk factors are then used by a machine learning model to calculate the 5-year risk of stroke, which thus also can be calculated for each timepoint in the simulated scenarios. We discuss and illustrate practical issues with clinical implementation, such as data gathering and harmonization. By improving patients’ understanding of their body and health, the digital twin can serve as a valuable tool for patient education and as a conversation aid during the clinical encounter. As such, it can facilitate shared decision-making, promote behavior change towards a healthy lifestyle, and improve adherence to prescribed medications.
- Top Cited PapersOpen Access
- 17 February 2022
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 1 (2) , e0000016
To explain or not to explain?—Artificial intelligence explainability in clinical decision support systems
Explainability for artificial intelligence (AI) in medicine is a hotly debated topic. Our paper presents a review of the key arguments in favor and against explainability for AI-powered Clinical Decision Support System (CDSS) applied to a concrete use case, namely an AI-powered CDSS currently used in the emergency call setting to identify patients with life-threatening cardiac arrest. More specifically, we performed a normative analysis using socio-technical scenarios to provide a nuanced account of the role of explainability for CDSSs for the concrete use case, allowing for abstractions to a more general level. Our analysis focused on three layers: technical considerations, human factors, and the designated system role in decision-making. Our findings suggest that whether explainability can provide added value to CDSS depends on several key questions: technical feasibility, the level of validation in case of explainable algorithms, the characteristics of the context in which the system is implemented, the designated role in the decision-making process, and the key user group(s). Thus, each CDSS will require an individualized assessment of explainability needs and we provide an example of how such an assessment could look like in practice.
- 17 February 2022
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 1 (2) , e0000016
Top Cited PapersOpen AccessTo explain or not to explain?—Artificial intelligence explainability in clinical decision support systems
Explainability for artificial intelligence (AI) in medicine is a hotly debated topic. Our paper presents a review of the key arguments in favor and against explainability for AI-powered Clinical Decision Support System (CDSS) applied to a concrete use case, namely an AI-powered CDSS currently used in the emergency call setting to identify patients with life-threatening cardiac arrest. More specifically, we performed a normative analysis using socio-technical scenarios to provide a nuanced account of the role of explainability for CDSSs for the concrete use case, allowing for abstractions to a more general level. Our analysis focused on three layers: technical considerations, human factors, and the designated system role in decision-making. Our findings suggest that whether explainability can provide added value to CDSS depends on several key questions: technical feasibility, the level of validation in case of explainable algorithms, the characteristics of the context in which the system is implemented, the designated role in the decision-making process, and the key user group(s). Thus, each CDSS will require an individualized assessment of explainability needs and we provide an example of how such an assessment could look like in practice.
- Open Access
- 13 April 2021
- Published by Taylor & Francis in International Journal of Public Administration
- Vol. 44 (9) , 715-727
Too Vulnerable to Involve? Challenges of Engaging Vulnerable Groups in the Co-production of Public Services through Research
Involving the public in the co-production of research to inform public service delivery can help to ensure the appropriateness of services. However, vulnerable groups are often systematically excluded from these activities. To raise awareness and stimulate discussion, this review 1) describes how vulnerable groups are currently involved in the co-production of research aimed at improving public services; (2) consolidates the challenges researchers encountered in these instances; and (3) produces an overview of the emergent solutions and recommendations for overcoming these challenges. The authors conclude that critical reflection, mutual learning, and capacity building can promote the involvement of vulnerable groups.
- 13 April 2021
- Published by Taylor & Francis in International Journal of Public Administration
- Vol. 44 (9) , 715-727
Open AccessToo Vulnerable to Involve? Challenges of Engaging Vulnerable Groups in the Co-production of Public Services through Research
Involving the public in the co-production of research to inform public service delivery can help to ensure the appropriateness of services. However, vulnerable groups are often systematically excluded from these activities. To raise awareness and stimulate discussion, this review 1) describes how vulnerable groups are currently involved in the co-production of research aimed at improving public services; (2) consolidates the challenges researchers encountered in these instances; and (3) produces an overview of the emergent solutions and recommendations for overcoming these challenges. The authors conclude that critical reflection, mutual learning, and capacity building can promote the involvement of vulnerable groups.
- Open Access
- 19 March 2021
- Published by Springer Nature in Spinal Cord
- Vol. 59 (5) , 493-503
The challenges characterizing the lived experience of caregiving. A qualitative study in the field of spinal cord injury
Study design: Qualitative exploratory study. Objectives: To explore the lived experience of SCI caregivers, with a focus on the challenges of their role. Setting: Caregivers of people with SCI living in the community in Switzerland. Methods: Data were collected through semi-structured interviews. Thematic analysis was performed. Results: The sample included 22 participants (16 women, 15 life partners) with a mean age of 61 years who had been caregivers for an average of 18 years. Caregiving in SCI seemed to be characterized by two phases. The first phase was relatively short and was central to becoming a caregiver; it was marked by challenges related to adjusting to the role of caregiver (e.g., dealing with shock, feeling unprepared). The second phase is lifelong and is characterized by a number of recurrent challenges related to balancing caregiving and personal life (e.g., having to prioritize caregiving over personal wishes, negotiating tasks and workload). Challenges related to lacking appropriate housing, facing financial uncertainty and dealing with bureaucracy were noted during both phases. Caregivers had to deal with these challenges to stay in step with life changes and newly emerging needs. Conclusions: Informal caregivers have a major role in supporting people with SCI. But their needs are not static. Any strategy to empower them has to adapt to an evolving role characterized by multiple tasks and challenges. A functional relationship between caregivers and care recipients is based on the recognition of their individualities and the different phases of adaptation, which is also an enriching process.
- 19 March 2021
- Published by Springer Nature in Spinal Cord
- Vol. 59 (5) , 493-503
Open AccessThe challenges characterizing the lived experience of caregiving. A qualitative study in the field of spinal cord injury
Study design: Qualitative exploratory study. Objectives: To explore the lived experience of SCI caregivers, with a focus on the challenges of their role. Setting: Caregivers of people with SCI living in the community in Switzerland. Methods: Data were collected through semi-structured interviews. Thematic analysis was performed. Results: The sample included 22 participants (16 women, 15 life partners) with a mean age of 61 years who had been caregivers for an average of 18 years. Caregiving in SCI seemed to be characterized by two phases. The first phase was relatively short and was central to becoming a caregiver; it was marked by challenges related to adjusting to the role of caregiver (e.g., dealing with shock, feeling unprepared). The second phase is lifelong and is characterized by a number of recurrent challenges related to balancing caregiving and personal life (e.g., having to prioritize caregiving over personal wishes, negotiating tasks and workload). Challenges related to lacking appropriate housing, facing financial uncertainty and dealing with bureaucracy were noted during both phases. Caregivers had to deal with these challenges to stay in step with life changes and newly emerging needs. Conclusions: Informal caregivers have a major role in supporting people with SCI. But their needs are not static. Any strategy to empower them has to adapt to an evolving role characterized by multiple tasks and challenges. A functional relationship between caregivers and care recipients is based on the recognition of their individualities and the different phases of adaptation, which is also an enriching process.
- Open Access
- 3 February 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2) , e0246524
Digital contact-tracing during the Covid-19 pandemic: An analysis of newspaper coverage in Germany, Austria, and Switzerland
Governments around the globe have started to develop and deploy digital contact tracing apps to gain control over the spread of the novel coronavirus (Covid-19). The appropriateness and usefulness of these technologies as a containment measure have since sparked political and academic discussions globally. The present paper contributes to this debate through an exploration of how the national daily newspapers in Germany, Austria, and Switzerland reported on the development and adoption of digital contact-tracing apps during early and after stages of the lockdown. These countries were among the first in Europe to develop apps and were critical voices in the debate of decentralized vs. centralized data processing. We conducted thematic analysis on news coverage published between January and May 2020 in high-circulation national daily newspapers from Germany, Austria, and Switzerland. A total of 148 articles from nine newspaper companies were included in the final analysis. From our analysis emerged six core themes of the development and adoption of digital contact tracing apps: 1) data governance; 2) role of IT giants; 3) scientific rigor; 4) voluntariness; 5) functional efficacy; 6) role of the app. These results shed light on the different facets of discussion regarding digital contact tracing as portrayed in German-speaking media. This study complements emerging survey data on public perceptions of digital contact tracing apps by providing a better understanding of the ideas circulating in the media ecosystem.
- 3 February 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2) , e0246524
Open AccessDigital contact-tracing during the Covid-19 pandemic: An analysis of newspaper coverage in Germany, Austria, and Switzerland
Governments around the globe have started to develop and deploy digital contact tracing apps to gain control over the spread of the novel coronavirus (Covid-19). The appropriateness and usefulness of these technologies as a containment measure have since sparked political and academic discussions globally. The present paper contributes to this debate through an exploration of how the national daily newspapers in Germany, Austria, and Switzerland reported on the development and adoption of digital contact-tracing apps during early and after stages of the lockdown. These countries were among the first in Europe to develop apps and were critical voices in the debate of decentralized vs. centralized data processing. We conducted thematic analysis on news coverage published between January and May 2020 in high-circulation national daily newspapers from Germany, Austria, and Switzerland. A total of 148 articles from nine newspaper companies were included in the final analysis. From our analysis emerged six core themes of the development and adoption of digital contact tracing apps: 1) data governance; 2) role of IT giants; 3) scientific rigor; 4) voluntariness; 5) functional efficacy; 6) role of the app. These results shed light on the different facets of discussion regarding digital contact tracing as portrayed in German-speaking media. This study complements emerging survey data on public perceptions of digital contact tracing apps by providing a better understanding of the ideas circulating in the media ecosystem.
- Open Access
- 1 January 2021
- Published by Springer Nature
- p. 57-71
Machine Learning in Stroke Medicine: Opportunities and Challenges for Risk Prediction and Prevention
Stroke is one of the leading causes of mortality and disability worldwide, causing individual hardship and high economic cost for society. Reducing the global burden of stroke depends on a multi-pronged mission, and experts agree an important strategy in this mission is prevention. Prevention success can be bolstered through the strategic development and adoption of risk prediction tools. However, there are several limitations to risk prediction models currently available. A solution to some of these limitations may be found in machine learning (ML), a promising tool that can improve our ability to assess risk and ultimately prevent strokes.This chapter surveys the global burden of stroke and describes current practices for reducing stroke incidence and stroke mortality rates. In particular, the chapter reviews how ML applications are applied to stroke risk prediction and prevention and identifies important technological and methodological challenges for using ML in these contexts. The chapter concludes by drawing the readers’ attention to some of the questions and ethical challenges that arise as clinicians widely adopt ML-based applications in practice.
- 1 January 2021
- Published by Springer Nature
- p. 57-71
Open AccessMachine Learning in Stroke Medicine: Opportunities and Challenges for Risk Prediction and Prevention
Stroke is one of the leading causes of mortality and disability worldwide, causing individual hardship and high economic cost for society. Reducing the global burden of stroke depends on a multi-pronged mission, and experts agree an important strategy in this mission is prevention. Prevention success can be bolstered through the strategic development and adoption of risk prediction tools. However, there are several limitations to risk prediction models currently available. A solution to some of these limitations may be found in machine learning (ML), a promising tool that can improve our ability to assess risk and ultimately prevent strokes.This chapter surveys the global burden of stroke and describes current practices for reducing stroke incidence and stroke mortality rates. In particular, the chapter reviews how ML applications are applied to stroke risk prediction and prevention and identifies important technological and methodological challenges for using ML in these contexts. The chapter concludes by drawing the readers’ attention to some of the questions and ethical challenges that arise as clinicians widely adopt ML-based applications in practice.